Ye Lin

Ye Lin


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2008 in European Journal of Oral Sciences
Verified
Journal Article
Closed access
PDF file
CYChen Yan
Chen Yan
YLYe Lin
Ye Lin
JZJin Zhen
Jin Zhen
LKLi Ke
Li Ke
LGLiu Gang
Liu Gang

1 April 2018 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
RJRonald E. Jung
Ronald E. Jung
VSVitor M. Sapata
Vitor M. Sapata
CHChristoph H. F. Hämmerle
Christoph H. F. Hämmerle
HWHui Wu
Hui Wu
XHXiu‐Lian Hu
Xiu‐Lian Hu
YLYe Lin
Ye Lin

28 December 2017 in Clinical Implant Dentistry and Related Research
Verified
Journal Article
Closed access
PDF file
JXJiang Xi
Jiang Xi
YZYu Zhang
Yu Zhang
PDPing Di
Ping Di
YLYe Lin
Ye Lin

3 January 2020 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
CWChen-Xi Wang
Chen-Xi Wang
XGXi-Yuan Ge
Xi-Yuan Ge
MWMing-Yue Wang
Ming-Yue Wang
TMTing Ma
Ting Ma
YZYu Zhang
Yu Zhang
YLYe Lin
Ye Lin
Background: Osteogenic differentiation of bone mesenchymal stem cells (BMSCs) is regulated by numerous signaling pathways. Dopamine (DA), a neurotransmitter, has previously been demonstrated to induce new bone formation by stimulating the receptors on BMSCs, but the essential mediators of DA-induced osteogenic signaling remain unclear. Methods: In this work, we evaluated the influence of both dopamine D1 and D2 receptor activation on BMSC osteogenic differentiation. Gene and protein expression of osteogenic-related markers were tested. The direct binding of transcriptional factor, Runx2, to those markers was also investigated. Additionally, cellular differentiation-associated signaling pathways were evaluated. Results: We showed that the expression level of the D1 receptor on BMSCs increased during osteogenic differentiation. A D1 receptor agonist, similar to DA, induced the osteogenic differentiation of BMSCs, and this phenomenon was effectively inhibited by a D1 receptor antagonist or by D1 receptor knockdown. Furthermore, the suppression of protein kinase A (PKA), an important kinase downstream of the D1 receptor, successfully inhibited DA-induced BMSC osteogenic differentiation and decreased the phosphorylation of ERK1/2. Compared with P38, MAPK, and JNK, DA mainly induced the phosphorylation of ERK1/2 and led to the upregulation of Runx2 transcriptional activity, thus facilitating BMSC osteogenic differentiation. On the other hand, an ERK1/2 inhibitor could reverse these effects. Conclusions: Taken together, these results suggest that ERK signaling may play an essential role in coordinating the DA-induced osteogenic differentiation of BMSCs by D1 receptor activation.

1 April 2016 in The Journal of Prosthetic Dentistry
Verified
Journal Article
Closed access
SRShuxin Ren
Shuxin Ren
YLYe Lin
Ye Lin
XHXiulian Hu
Xiulian Hu
YWYing Wang
Ying Wang

1 November 2010 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
YLYe Lin
Ye Lin
XHXiulian Hu
Xiulian Hu
AMArnulf-Reimar Metzmacher
Arnulf-Reimar Metzmacher
HLHaiyan Luo
Haiyan Luo
SHSusanne Heberer
Susanne Heberer
KNKatja Nelson
Katja Nelson